Clinical Trials in Le Kremlin-Bicêtre, Paris
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pancreatic Neuroendocrine TumorVon Hippel-Lindau DiseasePheochromocytoma/Paraganglioma+2 more
Merck Sharp & Dohme LLC322 enrolled84 locationsNCT04924075
Recruiting
Phase 2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
Hypochondroplasia
BioMarin Pharmaceutical60 enrolled26 locationsNCT07126262
Recruiting
Phase 2
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Noonan SyndromeTurner SyndromeShort Stature Homeobox- Containing Gene SHOX Deficiency
BioMarin Pharmaceutical54 enrolled24 locationsNCT06668805
Recruiting
Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Juvenile Psoriatic Arthritis
AbbVie40 enrolled31 locationsNCT06100744
Recruiting
Phase 1Phase 2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd.24 enrolled9 locationsNCT06525636
Recruiting
Not Applicable
Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery
OutcomeDecision Support System
Assistance Publique - Hôpitaux de Paris2,000 enrolled17 locationsNCT06011187